Sourcing BPC-157 outside regulated pharmaceutical channels carries risks of contamination, incorrect peptide sequencing, and inaccurate concentration levels, further undermining the legitimacy of benefit claims made without clinical trial support
Thus, in general, considering the known essential importance of the NO-system in eye functions [94,132,133,134,135,136], the evidence that BPC 157 therapy may cover both pharmacologically distinct NO-mechanisms (L-NAME vs
enhances wound healing and hair growth Benefits of GLOW Peptide Therapy The synergy of BPC-157, TB-500, and GHK-Cu in one injection yields a broad spectrum of benefits: 1
+ 70 % Collagen Synthesis vs 50% vitamin C and 40% retinoic acid in comparative in vitro models 4 000+ Genoa Gene Expression 31.2% of the human genome modulated: 1,942 genes activated, 762 deleted, 47 DNA repair genes 30 - 50 % Hair follicles Increased hair follicle size documented in hair studies 401.91 Da Molecular Weight GHK + Cu complex CAS 89030-95-5 | Formula CHNOCu -55.8 % Wrinkle Volume 12-week, double-blind, placebo-controlled facial study (71 women) Mechanism of Action Multi-Path Regeneration Epigenetic modulation, collagen synthesis and copper transport Primary Pathway Gene Expression Epigenetic Modulation GHK-Cu modulates the expression of over 4,000 human genes (31.2% of the genome)
B.DOronzioR.GarbettK.EbertP
